Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion type Assertion NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_head.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion description "[Given that the elevated levels of OPN is associated with advanced stages of NSCLC, elucidating OPN regulatory mechanisms may contribute to the development of a new therapeutic modality for NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_provenance.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion evidence source_evidence_literature NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_provenance.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion SIO_000772 17513004 NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_provenance.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion wasDerivedFrom befree-20140225 NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_provenance.
- NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_assertion wasGeneratedBy ECO_0000203 NP548291.RAv2Y56mgRDfFknW8zr04YYXuvN36Aj9C_MgfVEoXNQ_8130_provenance.